Advent Life Sciences closes pair of funds totalling $251m
Advent Life Sciences, a transatlantic venture firm focused on life science companies, has closed a pair of new funds totalling $215m.
Advent Life Sciences, a transatlantic venture firm focused on life science companies, has closed a pair of new funds totalling $215m.
Infrastructure, growth funds and LBO funds all saw secondaries pricing remain above 90% of par in the 90 days to the end of December, according to research by Setter Capital.
Wilshire has acquired a stake in Passion Capital's first vehicle from existing LPs, according to a source close to the situation.
Deloitte spins off restructuring arm to private equity-backed advisory firm
Paris-based venture capital house Five Seasons Ventures has launched a new vehicle, Food Tech Opportunity II, to target the European food technology sector, according to a regulatory filing.
Listed company Cellink has entered into an agreement to wholly acquire advanced robotics and diagnostics automation company Ginolis from venture capital firms Innovestor, Verso Capital and Finnvera, for €70m.
